publication date: Dec. 19, 2010

In this issue: 

FDA working on new ground rules for “adaptive” clinical trial designs.

ASCO picks University of Michigan Medical School Dean Allen Lichter as exective vice president and CEO.

UICC congress urges world commitment to cancer prevention.

Download (PDF 848KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.